Overview / Abstract: |
Target Audience Oncologists, oncology nurse practitioners, and oncology physician assistants. Program Overview Dr. Hurvitz and Dr Tolaney share key data and expert perspectives on approved and emerging HER-targeted therapies for metastatic breast cancer. Learning Objectives Upon completion of this educational activity, learners should be better able to: DESCRIBE the latest clinical advances in HER-directed therapies for advanced or metastatic breast cancer |
Expiration |
Feb 22, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
0.5 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
AstraZeneca and Daiichi Sankyo, Inc. |
Keywords / Search Terms |
Relias LLC FreeCME., Relias LLC., Breast Cancer Free CE CME |